These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. Jores K; Haberland A; Wartewig S; Mäder K; Mehnert W Pharm Res; 2005 Nov; 22(11):1887-97. PubMed ID: 16132349 [TBL] [Abstract][Full Text] [Related]
6. Penetration of Nile red-loaded nanostructured lipid carriers (NLCs) across the porcine cornea. Niamprem P; Srinivas SP; Tiyaboonchai W Colloids Surf B Biointerfaces; 2019 Apr; 176():371-378. PubMed ID: 30658285 [TBL] [Abstract][Full Text] [Related]
7. Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies. Araújo J; Garcia ML; Mallandrich M; Souto EB; Calpena AC Nanomedicine; 2012 Aug; 8(6):1034-41. PubMed ID: 22115598 [TBL] [Abstract][Full Text] [Related]
8. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability. Teeranachaideekul V; Müller RH; Junyaprasert VB Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778 [TBL] [Abstract][Full Text] [Related]
9. Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique. Severino P; Santana MH; Souto EB Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1375-9. PubMed ID: 24364934 [TBL] [Abstract][Full Text] [Related]
10. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662 [TBL] [Abstract][Full Text] [Related]
11. Bupivacaine (S75:R25) Loaded in Nanostructured Lipid Carriers: Factorial Design, HPLC Quantification Method and Physicochemical Stability Study. Da Silva GHR; de Morais Ribeiro LN; Guilherme VA; de Castro SR; Breitkreitz MC; de Paula E Curr Drug Deliv; 2018; 15(3):388-396. PubMed ID: 28745230 [TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization, identification and improved photo-stability of α-lipoic acid-loaded nanostructured lipid carrier. Wang J; Tang J; Zhou X; Xia Q Drug Dev Ind Pharm; 2014 Feb; 40(2):201-10. PubMed ID: 23336811 [TBL] [Abstract][Full Text] [Related]
13. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Khan S; Baboota S; Ali J; Narang RS; Narang JK Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780 [TBL] [Abstract][Full Text] [Related]
14. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine. Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388 [TBL] [Abstract][Full Text] [Related]
15. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug. Zhang WL; Gu X; Bai H; Yang RH; Dong CD; Liu JP Int J Pharm; 2010 May; 391(1-2):313-21. PubMed ID: 20214958 [TBL] [Abstract][Full Text] [Related]
16. Cutting-edge advances in therapy for the posterior segment of the eye: Solid lipid nanoparticles and nanostructured lipid carriers. de Oliveira IF; Barbosa EJ; Peters MCC; Henostroza MAB; Yukuyama MN; Dos Santos Neto E; Löbenberg R; Bou-Chacra N Int J Pharm; 2020 Nov; 589():119831. PubMed ID: 32877729 [TBL] [Abstract][Full Text] [Related]
17. Topical instillation of triamcinolone acetonide-loaded emulsomes for posterior ocular delivery: statistical optimization and in vitro-in vivo studies. Kapadia R; Parikh K; Jain M; Sawant K Drug Deliv Transl Res; 2021 Jun; 11(3):984-999. PubMed ID: 32567039 [TBL] [Abstract][Full Text] [Related]
18. [Preparation of isopsoralen loaded nanostructured carrier and its in vitro transdermal permeation characteristics]. Pang JY; Liu X; Shen BD; Shen CY; Lian WQ; Liu J; Hu CX; Zhong RN; Xu RC; Yuan HL Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2473-2478. PubMed ID: 28840686 [TBL] [Abstract][Full Text] [Related]
19. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles. Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282 [TBL] [Abstract][Full Text] [Related]